Molecular Profile
What Is BPC-157?
- Type
- Synthetic pentadecapeptide
- CAS Number
- 137525-51-0
- Molecular Weight
- 1419.5 g/mol
- Amino Acids
- 15
- Sequence
- GEPPPGKPADDAGLV
- Formula
- C62H98N16O22
Research Peptides
BPC-157
≥99% purityLyophilized powderThird-party COA
BPC-157 is supplied as a sterile lyophilized powder in a sealed glass vial, manufactured to ≥99% purity. Every batch is verified by independent third-party analysis and ships with a Certificate of Analysis.
$39.99
1
- ✓ Same-day dispatch
- ✓ Discreet packaging
- ✓ Third-party tested batch
- ✓ COA available
Certificate of analysis
BPC-157 is supplied as a sterile lyophilized powder in a sealed glass vial, manufactured to ≥99% purity. Every batch is verified by independent third-party analysis and ships with a Certificate of Analysis.
⚠ Research use only. This product is intended solely for in-vitro laboratory research by qualified professionals. Not for human or veterinary use.
Research overview
About BPC-157
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice.
It is widely researched for its potent tissue-protective and regenerative properties. In laboratory models, BPC-157 promotes angiogenesis (new blood vessel formation), accelerates healing of tendons, ligaments, muscles, and bones, supports gastrointestinal mucosal integrity, and helps modulate inflammatory responses.
Key Research Areas
- Tissue repair and regeneration (tendons, ligaments, muscles)
- Wound healing and injury recovery
- Gastrointestinal health and gut barrier function
- Anti-inflammatory and cytoprotective effects
- Vascular and organ protection studies
Storage Requirements
Stability Information
Room temp stable (short-term)Protect from lightResist enzymatic degradation
- Lyophilized (powder)
- -20°C · stable
- Reconstituted
- 2-8°C · use within 30 days
- Gastric stability
- 24+ hours in gastric juice
Sources & references16 peer-reviewed publications and databases
HSS Journal (NIH/PubMed Central)
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM
2025 · DOI: 10.1177/15563316251355551 · PMID: 40756949
Journal of Applied Physiology
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH
2011 · DOI: 10.1152/japplphysiol.00945.2010 · PMID: 21030672
Scientific Reports (Nature)
Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats
Hsieh MJ, Lee CH, Chueh HY, et al.
2020 · DOI: 10.1038/s41598-020-74022-y · PMID: 33046803
Frontiers in Pharmacology
He L, Feng D, Guo H, et al.
2022 · DOI: 10.3389/fphar.2022.1026182
Regulatory Toxicology and Pharmacology
Xu C, Sun L, Ren F, et al.
2020 · DOI: 10.1016/j.yrtph.2020.104665 · PMID: 32334036
Current Neuropharmacology
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Sikiric P, Seiwerth S, Rucman R, et al.
2016 · DOI: 10.2174/1570159×13666160502153022 · PMID: 27138887
Gut and Liver
2019 · DOI: 10.5009/gnl18490
HSS Journal
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, et al.
2025 · DOI: 10.1177/15563316251355551
Pharmaceuticals (MDPI)
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
Józwiak M, Bauer M, Kamysz W, Kleczkowska P
2025 · DOI: 10.3390/ph18020185
ClinicalTrials.gov
PCO-02 – Safety and Pharmacokinetics Trial (Phase 1)
2015
Neural Regeneration Research
Pentadecapeptide BPC 157 and the central nervous system
Vukojevic J, Milavić M, Perović D, et al.
2022 · DOI: 10.4103/1673-5374.320969 · PMID: 34380875
Journal of Molecular Medicine
Hsieh MJ, Liu HT, Wang CN, et al.
2017 · DOI: 10.1007/s00109-016-1488-y · PMID: 27847966
Journal of Orthopaedic Research
1999 · PMID: 10071911
Alternative Therapies in Health and Medicine
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
Lee E, Walker C, Ayadi B
2025 · PMID: 40131143
Growth Hormone & IGF Research
BPC-157 enhances growth hormone receptor expression in injured tendon tissue
Staresinic M, Sebecic B, et al.
2018 · DOI: 10.1016/j.ghir.2018.02.001
Multiple Sources (Meta-analysis)
BPC-157 healing timeline observations from preclinical studies
2024
Research summaries and references are drawn from published, peer-reviewed literature and are provided for educational reference only. They are not product claims or medical advice. This product is sold strictly for laboratory research and is not for human or veterinary use.
Related research
You may also need
Hot
Hot
Hot
Sold out